Valeo Financial Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,123
| Closed | -$311K | – | 619 |
|
|
2021
Q1 | $311K | Sell |
4,123
-150
| -4% | -$11.3K | 0.01% | 340 |
|
|
2020
Q4 | $375K | Buy |
4,273
+3,623
| +557% | +$318K | 0.02% | 288 |
|
|
2020
Q3 | $49K | Buy |
650
+95
| +17% | +$7.16K | ﹤0.01% | 652 |
|
|
2020
Q2 | $68K | Sell |
555
-395
| -42% | -$48.4K | 0.01% | 594 |
|
|
2020
Q1 | $76K | Sell |
950
-774
| -45% | -$61.9K | 0.01% | 471 |
|
|
2019
Q4 | $146K | Buy |
1,724
+500
| +41% | +$42.3K | 0.01% | 384 |
|
|
2019
Q3 | $82K | Buy |
1,224
+6
| +0.5% | +$402 | 0.01% | 476 |
|
|
2019
Q2 | $104K | Buy |
1,218
+1,200
| +6,667% | +$102K | 0.01% | 424 |
|
|
2019
Q1 | $2K | Sell |
18
-41
| -69% | -$4.56K | ﹤0.01% | 1329 |
|
|
2018
Q4 | $5K | Hold |
59
| – | – | ﹤0.01% | 1051 |
|
|
2018
Q3 | $5K | Hold |
59
| – | – | ﹤0.01% | 1166 |
|
|
2018
Q2 | $6K | Buy |
+59
| New | +$6K | ﹤0.01% | 1066 |
|
|
2018
Q1 | – | Sell |
-52
| Closed | -$5K | – | 1543 |
|
|
2017
Q4 | $5K | Sell |
52
-13
| -20% | -$1.25K | ﹤0.01% | 990 |
|
|
2017
Q3 | $6K | Buy |
+65
| New | +$6K | ﹤0.01% | 812 |
|